Expensive Drugs from Pfizer, Other Companies Targeted for First U.S. Price Negotiations

  • 📰 WSJ
  • ⏱ Reading Time:
  • 14 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 9%
  • Publisher: 63%

Business News News

Business Business Latest News,Business Business Headlines

Lower prices would take effect in 2026 depending on the talks between the U.S. and drugmakers and the outcome of industry lawsuits.

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.

https://www.wsj.com/health/pharma/expensive-drugs-from-pfizer-other-companies-targeted-for-first-u-s-price-negotiations-9942b20bLower prices would take effect in 2026 depending on the talks between the U.S. and drugmakers and the outcome of industry lawsuits

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 98. in BUSİNESS

Business Business Latest News, Business Business Headlines